{{PBB/7012}}
{{Infobox rfam
| Name = 脊椎動物端粒酶RNA
| image = RF00024.jpg
| height = 276px
| caption = 
| Symbol = Telomerase-vert
| AltSymbols = 
| Rfam = RF00024
| RNA_type = [[基因|基因]]
| Tax_domain = [[真核|真核]]、[[病毒|病毒]]
| CAS_number = 
| EntrezGene =
| HGNCid =
| OMIM = 
| PDB = 
| RefSeq = 
| Chromosome = 
| Arm = 
| Band = 
| LocusSupplementaryData = 
}}
{{Infobox rfam
| Name = 纖毛蟲端粒酶RNA
| image = RF00025.jpg
| width= 240px
| caption = 
| Symbol = Telomerase-cil
| AltSymbols = 
| Rfam = RF00025
| RNA_type = [[基因|基因]]
| Tax_domain = [[真核生物|真核生物]]
| CAS_number = 
| EntrezGene = 
| HGNCid = 
| OMIM = 
| PDB = 
| RefSeq = 
| Chromosome = 
| Arm = 
| Band = 
| LocusSupplementaryData = 
}}
{{Infobox rfam
| Name = 釀酒酵母端粒酶RNA
| image = RF01050.png
| width= 240px
| caption = 
| Symbol = Sacc telomerase
| AltSymbols = 
| Rfam = RF01050
| RNA_type = [[基因|基因]]
| Tax_domain = [[真核生物|真核生物]]
| CAS_number = 
| EntrezGene = 
| HGNCid = 
| OMIM = 
| PDB = 
| RefSeq = 
| Chromosome = 
| Arm = 
| Band = 
| LocusSupplementaryData = 
}}

'''端粒酶RNA組分'''（{{lang-en|telomerase RNA component}}，缩写为{{lang|en|TERC}}）或称'''端粒酶RNA'''，是一種[[真核生物|真核生物]]的[[非編碼RNA|非編碼RNA]]（ncRNA）。它是[[端粒酶|端粒酶]]的組成成分之一——端粒酶用它來延長端粒<ref name="pmid7544491">{{cite journal |vauthors = Feng J, Funk WD, Wang SS, Weinrich SL, Avilion AA, Chiu CP, Adams RR, Chang E, Allsopp RC, Yu J | title = The RNA component of human telomerase | journal = Science | volume = 269 | issue = 5228 | pages = 1236–41 |date=September 1995 | pmid = 7544491 | doi = 10.1126/science.7544491| url = }}</ref><ref name="pmid16319170">{{cite journal |vauthors=Jády BE, Richard P, Bertrand E, Kiss T | title = Cell Cycle-dependent Recruitment of Telomerase RNA and Cajal Bodies to Human Telomeres | journal = Mol. Biol. Cell | volume = 17 | issue = 2 | pages = 944–54 |date = February 2006 | pmid = 16319170 | pmc = 1356602 | doi = 10.1091/mbc.E05-09-0904 | url = }}</ref>。端粒酶RNA在[[DNA複製|DNA複製]]過程中，爲端粒的[[逆轉錄|逆轉錄]]過程提供模板。酵母、纖毛蟲、脊椎動物的端粒酶RNA的序列和結構都有很大不同。不過，它們的5'端靠近模板序列處，都有一個[[假結結構|假結結構]]。脊椎動物端粒酶RNA的3'端有一個與[[snoRNA|snoRNA]]（核仁RNA）類似的結構域<ref>{{cite journal | last = McCormick-Graham | first = M |author2=Romero DP  | year = 1995 | title = Ciliate telomerase RNA structural features | journal = Nucleic Acids Res | volume = 23 | pages = 1091–1097 | pmid = 7739888 | doi = 10.1093/nar/23.7.1091 | issue = 7 | pmc = 306816}}</ref><ref>{{cite journal | last = Lingner | first = J |author2=Hendrick LL |author3=Cech TR | year = 1994 | title = Telomerase RNAs of different ciliates have a common secondary structure and a permuted template | journal = Genes Dev | volume = 8 | pages = 1984–1998 | pmid = 7958872 | doi = 10.1101/gad.8.16.1984 | issue = 16}}</ref><ref name="pmid16713250">{{cite journal |vauthors=Theimer CA, Feigon J | title = Structure and function of telomerase RNA | journal = Curr. Opin. Struct. Biol. | volume = 16 | issue = 3 | pages = 307–18 | year = 2006 | pmid = 16713250 | doi = 10.1016/j.sbi.2006.05.005 }}</ref>。

== 功能 ==
端粒酶係一類核糖核蛋白聚合酶。它通過給端粒加上重複序列來維持其長度。該重複序列在不同真核生物間有很大不同（具體可參見[[端粒#結構|端粒]]條目中的比較表）。端粒酶除RNA外，還含有蛋白質組分（{{link-en|端粒酶逆轉錄酶|Telomerase reverse transcriptase|TERT}}，端粒酶逆轉錄酶）。端粒酶的蛋白質組分具有[[逆轉錄酶|逆轉錄酶]]的活性。端粒酶的RNA組分，即端粒酶RNA，充當逆轉錄的模板。在脊椎動物端粒酶序列中，作爲模板的CCCUAA序列在50位左右出現。端粒酶的表達在細胞衰老中扮演重要角色，在成熟[[體細胞|體細胞]]中，端粒酶的表达通常處於受抑制狀態，因而端粒會不斷縮短。體細胞的端粒酶表达失調可能會誘發[[癌變|癌變]]。對小鼠的研究表明，端粒酶亦參與[[DNA修復|染色體修復]]，因爲在雙鏈都損壞的情況下，可能需要從頭合成端粒重複序列<ref name="entrez" />。在[[皰疹病毒|皰疹病毒]]亦發現了與端粒酶RNA[[同源|同源]]的RNA<ref name=Fragnet>{{cite journal | last = Fragnet | first = L |author2=Kut E |author3=Rasschaert D  | year = 2005 | title = Comparative functional study of the viral telomerase RNA based on natural mutations | journal = J Biol Chem. | volume = 280 | pages = 23502–23515 | pmid = 15811851 | doi = 10.1074/jbc.M501163200 | issue = 25}}</ref>。

== 臨床意義 ==
編碼端粒酶RNA的基因的突變會造成造成常染色體顯性遺傳的{{link-en|先天性角化不良|dyskeratosis congenita}}，也有可能與某些類型的再生障礙性貧血有關<ref name="entrez">{{cite web |title = Entrez Gene: TERC telomerase RNA component |url = http://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=7012| accessdate = }}</ref>。

== 参考文献  ==
{{Reflist}}

== 拓展閱讀 ==
{{refbegin}}
* {{cite journal |vauthors = de Lange T, Jacks T |title=For better or worse? Telomerase inhibition and cancer |journal=Cell |volume=98 |issue= 3 |pages= 273–5 |year = 1999 |pmid = 10458601 |doi = 10.1016/S0092-8674(00)81955-8 }}
* {{cite journal |vauthors=Marrone A, Dokal I |title=Dyskeratosis congenita: molecular insights into telomerase function, ageing and cancer |journal=Expert Reviews in Molecular Medicine |volume=6 |issue= 26 |pages= 1–23 |year= 2007 |pmid= 15613268 |doi= 10.1017/S1462399404008671 }}
* {{cite journal |author=Yamaguchi H |title=Mutations of telomerase complex genes linked to bone marrow failures |journal=Journal of Nippon Medical School = Nihon Ika Daigaku zasshi |volume=74 |issue= 3 |pages= 202–9 |year= 2007 |pmid= 17625368 |doi=  10.1272/jnms.74.202}}
* {{cite journal  |vauthors=Zaug AJ, Linger J, Cech TR |title=Method for determining RNA 3' ends and application to human telomerase RNA |journal=Nucleic Acids Res. |volume=24 |issue= 3 |pages= 532–3 |year= 1996 |pmid= 8602368 |doi=10.1093/nar/24.3.532  | pmc=145649  }}
* {{cite journal |author=Soder AI |title=Mapping of the gene for the mouse telomerase RNA component, Terc, to chromosome 3 by fluorescence in situ hybridization and mouse chromosome painting |journal=Genomics |volume=41 |issue= 2 |pages= 293–4 |year= 1997 |pmid= 9143511 |doi= 10.1006/geno.1997.4621  |name-list-format=vanc| author2=Hoare SF |author3=Muire S |display-authors=3 | last4=Balmain |first4=Allan | last5=Parkinson | first5=E.Kenneth  | last6=Keith  | first6=W.Nicol }}
* {{cite journal |author=Zhao JQ |title=Cloning and characterization of human and mouse telomerase RNA gene promoter sequences |journal=Oncogene |volume=16 |issue= 10 |pages= 1345–50 |year= 1998 |pmid= 9546436 |doi= 10.1038/sj.onc.1201892  |name-list-format=vanc |author2=Hoare SF |author3=McFarlane R  | display-authors=3  | last4=Muir | first4=Sharon  | last5=Parkinson |first5=E Kenneth | last6=Black  | first6=Donald M  | last7=Keith  | first7=W Nicol }}
* {{cite journal |vauthors=Mitchell JR, Wood E, Collins K |title=A telomerase component is defective in the human disease dyskeratosis congenita |journal=Nature |volume=402 |issue = 6761 |pages = 551–5 |year= 1999 |pmid = 10591218 |doi= 10.1038/990141 }}
* {{cite journal  |vauthors=Chen JL, Blasco MA, Greider CW |title=Secondary structure of vertebrate telomerase RNA |journal=Cell |volume=100 |issue= 5 |pages= 503–14 |year= 2000 |pmid = 10721988 |doi=10.1016/S0092-8674(00)80687-X  }}
*{{cite journal | author=Wong KK |title=Telomere dysfunction impairs DNA repair and enhances sensitivity to ionizing radiation |journal=Nat. Genet. |volume=26 |issue= 1 |pages= 85–8 |year= 2000 |pmid= 10973255 |doi= 10.1038/79232  |name-list-format=vanc| author2=Chang S  | author3=Weiler SR  | display-authors=3  | last4=Weiler |first4=Sarah R.  | last5=Ganesan  | first5=Shridar  | last6=Chaudhuri  | first6=Jayanta  | last7=Zhu  | first7=Chengming  | last8=Artandi  | first8=Steven E. | last9=Rudolph  | first9=Karl Lenhard }}
*{{cite journal |vauthors=Mitchell JR, Collins K |title=Human telomerase activation requires two independent interactions between telomerase RNA and telomerase reverse transcriptase |journal=Mol. Cell |volume=6 |issue= 2 |pages= 361–71 |year= 2000 |pmid= 10983983 |doi=10.1016/S1097-2765(00)00036-8  }}
* {{cite journal |author=Imoto I |title=SNO is a probable target for gene amplification at 3q26 in squamous-cell carcinomas of the esophagus |journal=Biochem. Biophys. Res. Commun. |volume=286 |issue= 3 |pages= 559–65 |year= 2001 |pmid= 11511096 |doi= 10.1006/bbrc.2001.5428  |name-list-format=vanc| author2=Pimkhaokham A  | author3=Fukuda Y  | display-authors=3 |last4=Yang |first4=Zeng-Quan  | last5=Shimada  | first5=Yutaka  | last6=Nomura  | first6=Nobuo  | last7=Hirai  | first7=Hisamaru | last8=Imamura  | first8=Masayuki  |last9=Inazawa  | first9=Johji }}
* {{cite journal | author=Vulliamy T |title=The RNA component of telomerase is mutated in autosomal dominant dyskeratosis congenita |journal=Nature |volume=413 |issue= 6854 |pages= 432–5 |year= 2001 |pmid= 11574891 |doi= 10.1038/35096585  |name-list-format=vanc| author2=Marrone A  | author3=Goldman F  | display-authors=3  | last4=Dearlove | first4=Andrew  | last5=Bessler  | first5=Monica  | last6=Mason  | first6=Philip J.  | last7=Dokal  | first7=Inderjeet }}
* {{cite journal | author=Pruzan R |title=Allosteric inhibitors of telomerase: oligonucleotide N3′→P5′ phosphoramidates |journal=Nucleic Acids Res. |volume=30 |issue= 2 |pages= 559–68 |year= 2002 |pmid= 11788719 |doi=10.1093/nar/30.2.559  | pmc=99832  |name-list-format=vanc| author2=Pongracz K  | author3=Gietzen K  | display-authors=3 | last4=Wallweber  | first4=G  | last5=Gryaznov  | first5=S  }}
* {{cite journal |vauthors=Zhang RG, Zhang RP, Wang XW, Xie H |title=Effects of cisplatin on telomerase activity and telomere length in BEL-7404 human hepatoma cells |journal=Cell Res. |volume=12 |issue= 1 |pages= 55–62 |year= 2004 |pmid= 11942411 |doi= 10.1038/sj.cr.7290110 }}
* {{cite journal | author=Yang Y |title=Nucleolar localization of hTERT protein is associated with telomerase function |journal=Exp. Cell Res. |volume=277 |issue= 2 |pages= 201–9 |year= 2002 |pmid= 12083802 |doi=10.1006/excr.2002.5541  |name-list-format=vanc| author2=Chen Y  | author3=Zhang C  | display-authors=3  | last4=Huang  | first4=H  | last5=Weissman  | first5=SM  }}
* {{cite journal  | author=Chang JT |title=Differential regulation of telomerase activity by six telomerase subunits |journal=Eur. J. Biochem. |volume=269 |issue= 14 |pages= 3442–50 |year= 2002 |pmid= 12135483 |doi=10.1046/j.1432-1033.2002.03025.x  |name-list-format=vanc| author2=Chen YL  | author3=Yang HT  | display-authors=3  |last4=Chen |first4=Chi-Yuan |last5=Cheng |first5=Ann-Joy  }}
* {{cite journal |vauthors=Gavory G, Farrow M, Balasubramanian S |title=Minimum length requirement of the alignment domain of human telomerase RNA to sustain catalytic activity in vitro |journal=Nucleic Acids Res. |volume=30 |issue= 20 |pages= 4470–80 |year= 2002 |pmid= 12384594 |doi=10.1093/nar/gkf575  | pmc=137139  }}
* {{cite journal | author=Sood AK |title=p53 null mutations are associated with a telomerase negative phenotype in ovarian carcinoma |journal=Cancer Biol. Ther. |volume=1 |issue= 5 |pages= 511–7 |year= 2003 |pmid= 12496479 |doi=  10.4161/cbt.1.5.167|name-list-format=vanc| author2=Coffin J  | author3=Jabbari S  | display-authors=3 |last4=Buller  | first4=RE  | last5=Hendrix  | first5=MJ  | last6=Klingelhutz  | first6=A  }}
* {{cite journal | last = Antal | first = M |author2=Boros E |author3=Solymosy F |author4=Kiss T  | year = 2002 | title = Analysis of the structure of human telomerase RNA in vivo | journal = Nucleic Acids Res | volume = 30 | pages = 912–920 | pmid = 11842102 | doi = 10.1093/nar/30.4.912 | issue = 4 | pmc = 100349}}
{{refend}}

== 外部連結 ==
* [http://www.ncbi.nlm.nih.gov/bookshelf/br.fcgi?book=gene&part=dkc  GeneReviews/NCBI/NIH/UW entry on Dyskeratosis Congenita]
* [http://www.ncbi.nlm.nih.gov/bookshelf/br.fcgi?book=gene&part=pf  GeneReviews/NCBI/NIH/UW entry on Pulmonary Fibrosis, Familial]
* [http://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=7012 EntrezGene page for TERC]
* {{Rfam|id=RF00024|name=Vertebrate telomerase RNA}}
* {{Rfam|id=RF00025|name=Ciliate telomerase RNA}}
* {{Rfam|id=RF01050|name=Saccharomyces telomerase}}

{{-}}
{{RNA类型}}
{{DNA複製}}

[[Category:非編碼RNA|Category:非編碼RNA]]
[[Category:端粒|Category:端粒]]